Wyatt Investment Research login

 
Forgot password? Not a Subscriber? - Start Here
 
 
HOMEWEEKLY NEWSLETTERMODEL PORTFOLIOSPECIAL REPORTSVIDEO UPDATESCUSTOMER SERVICE
 
 

Tag - Scrx

 

 
Kevin Pendley

Volatile day ends with mild dip for small caps

Small-cap stocks turned lower Tuesday, rejecting an impressive morning rally as financial and tech stocks failed to gain traction even with the benefit of a sharp pullback in crude oil prices. The Russell 2000 (NYSE:IWM) closed down 0.99, or 0.13%, at 738.51. For the year, the Russell is down 3.5%, which is quite a shift from the morning rally when the Russell looked poised to post one of the highest daily settlements of the year. The selling pot was stirred among large caps too, with the Dow slipping 0.2% on the day; the Dow is now down 13.1% for the year. In addition, the S&P 500 lost 0.4% Tuesday and is off 13% for 2008.

The dramatic reversal in fortune for stocks today left a mild bearish reversal formation on daily charts as the Russell closed lower after threatening to challenge move highs in the morning. In addition, when a market sinks in the face of seemingly bullish news, it is often considered a classic signal that something else is wrong. In this case, the market seems to be saying that a little relief at the gas pump isn’t enough to fix what ails the economy or the credit crisis.

It’s interesting to note too that the erosion in stocks seemed to coincide with a surge in Treasury markets. The yield on the benchmark 10-year note tumbled nearly 2% to the lowest closing level since late April. Yields move inversely to price, which means that demand for Treasury products (a traditional safe-haven) was strong today. Some of that push for a safety net seemed to move in tandem with the Fitch downgrade of paper debt for mortgage lending giants Fannie Mae (NYSE:FNM) and Freddie Mac (NYSE:FRE). If there were concerns in the market about the government-sponsored enterprises, they didn’t really show up in the stock, as shares in FNM rose 8%, while FRE jumped 14%.

The day dawned brightly for equities as investors embraced a huge slide in crude oil prices. Even though the stock market turned lower in the afternoon, crude oil prices still lost about 5% on the day, sinking $5.75 a barrel to $109.71. The stiff decline in energy prices was accompanied by a big rally in the U.S. dollar, and a whole host of commodity markets succumbed to the pressure — all of which would seem . . .

[ More » ]
Jennifer Schonberger

Starrett LS, First Financial and Sciele Pharma among 52-week highs

Starrett LS Co. (Nasdaq:SCX), First Financial Corp. (Nasdaq:THFF) and Sciele Pharma Inc. (Nasdaq:SCRX) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.         

Also included among the results: CombiMatrix Corp. (Nasdaq:CBMX), Standex International Corp. (Nasdaq:SXI), Home Diagnostics Inc. (Nasdaq:HDIX), Medivation Inc. (Nasdaq:MDVN), DXP Enterprises Inc. (Nasdaq:DXPE) and Datascope Corp. (Nasdaq:DSCP).         

Here are the new 52-week highs among small caps: 

[ More » ]
Jennifer Schonberger

Small caps remain in the green as crude sell off continues

After kicking off September with a bang, small caps remain in positive territory midday, as oil futures plummeted after Hurricane Gustav proved less destructive than previously thought.

At 12:10 p.m. ET, the Russell 2000 (NYSE:IWM) was up 3.92, or 0.53%, at 743.42, but off its highs.

Crude oil prices took a nose dive today after Hurricane Gustav’s arrival over the weekend spared key energy production facilities in the Gulf of Mexico. Midday, a barrel of light sweet crude has deflated $6.38 to roughly $109. Crude prices were down as much as $10 before the market opening. Oil’s sell off was welcome news for the market, as that potentially points to lower gas prices and eases consumers’ allotment for expenditures on energy. Additionally, the summer, which is marked as a high traveling season, has come to a close, marking the beginning of a period for weaker seasonal demand.

As crude sold off, the dollar surged higher. Midday, the greenback has breached new highs at $1.4526. Aside from crude, more signs of a weakening global economy also pushed the dollar higher. The central bank of Australia slashed interest rates by 25 basis points in an effort to aid a worsening economy. In England, the head of the UK Treasury, Alistair Darling, commented that the country’s economic conditions are the worst in 60 years, while the OECD noted that Britain is the closest to recession in Europe.

[ More » ]
Jennifer Schonberger

Sciele Pharma, International Shipholding and West Marine lead small-cap percentage gainers

Sciele Pharma Inc. (Nasdaq:SCRX), International Shipholding Corp. (Nasdaq:ISH) and West Marine Inc. (Nasdaq:WMAR) are among the biggest percentage gainers in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Union Drilling Inc. (Nasdaq:UDRL), UAL Corp. (Nasdaq:UAUA), PacWest Bancorp (Nasdaq:PACW), Cooper Tire & Rubber Co. (Nasdaq:CTB), DineEquity Inc. (Nasdaq:DIN) and Einstein Noah Restaurant Group Inc. (Nasdaq:BAGL).

Here are the biggest percentage gainers among small caps:

[ More » ]
Kevin Pendley

Bulls charging after Gustav destruction not as bad as feared

Small-cap stocks shot higher this morning, as the bulls came charging out of the gate when crude oil prices collapsed overnight. At 10:01 a.m. ET, the Russell 2000 (NYSE:IWM) was up 12.03, or 1.63%, at 751.53.

Crude oil prices fell hard today as Hurricane Gustav hit landfall in Louisiana, but appeared to spare key Gulf of Mexico energy production facilities. At one point ahead of the stock market opening, crude oil prices were down some $9 dollars a barrel, tumbling below $107. If the energy market remains under pressure, then prices at the gasoline pump should fall, which would provide relief to consumers and shift money back toward other expenditures.

The ISM Manufacturing Survey came in at 49.9, which was just a tad above the forecast of 49.6. The market reaction to the data was relatively tame, with trader attention focused more on the commodity arena.

Small caps were pacing the early advance in equities this morning, just slightly outperforming the Dow and topping the S&P 500 by about 0.5%. Speaking of the S&P 500, that index product was testing important resistance along the 1,300 line, which has been a difficult hurdle to jump in recent weeks. Definitive price action above 1,300 could trigger some new money into stocks and prod short-covering from traders who have been successfully shorting rallies in stocks in recent weeks.

The U.S. dollar was in full rally mode this morning, parlaying the collapse in energy prices to higher territory. The greenback stormed to fresh move highs against the euro, climbing 0.9% to the highest point since early February. In addition, the dollar was up about 0.8% versus the yen. The combination of a soaring buck and sinking crude tugged at a host of commodity markets, with gold down 4% and cocoa . . .

[ More » ]
Jennifer Schonberger

Sciele Pharma acquired by Japan’s Shionogi for $1.1 billion

Shares of Sciele Pharma, Inc. (Nasdaq:SCRX) are rocketing in pre-market trading after the small biopharmaceutical company said Monday that it will be acquired by Japanese pharmaceutical manufacturer Shionogi & Co for $31 per share, or $1.1 billion in aggregate. The buyout price represents a 61% premium over Sciele’s closing price on Friday. This is just another sign that lower stock prices domestically are enticing foreign buyers. 

Shares jumped 59%, or $11.27, to $30.54 in pre-market trading. For detailed price information and news stories on Sciele Pharma, click SCRX.

[ More » ]
Jennifer Schonberger

Sciele Pharma, Isle of Capri Casinos and Ameristar Casinos lead small-cap volume in pre-market

Sciele Pharma Inc. (Nasdaq:SCRX), Isle of Capri Casinos Inc. (Nasdaq:ISLE) and Ameristar Casinos Inc. (Nasdaq:ASCA) are among the most actively traded companies in Monday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Odyssey Healthcare Inc. (Nasdaq:ODSY), Progenics Pharmaceuticals Inc. (Nasdaq:PGNX), Avid Technology Inc. (Nasdaq:AVID), Salix Pharmaceuticals Ltd. (Nasdaq:SLXP), Morgans Hotel Group Co. (Nasdaq:MHGC) and CV Therapeutics Inc. (Nasdaq:CVTX).

Here are the most actively traded companies among small caps:

[ More » ]
Kevin Pendley

Bank failures, safe-haven flows pummel small caps

Small-cap stocks turned a sleepy morning erosion into a full-blown afternoon debacle, as worries about the financial system renewed concerns about any near-term economic recovery and sparked money flow away from equities. The Russell 2000 (NYSE:IWM) closed down 14.23, or 2%, at 696.11.

The trigger for today’s sell-off appeared to be news that FDIC regulators seized two small banks that failed over the weekend, and sold them off to Mutual Omaha Bank. The immediate beneficiary of these systemic financial worries was the Treasury market, with bond and notes lifted by safe-haven flows out of stocks. The yield on the benchmark 10-year note tumbled over 2% as cash 10s rallied.

With nearly one-fourth of the S&P 500 reporting earnings this week, the early-week focus was expected to be squarely on the profit picture, giving the market time to shift into “macro-economic” gear later this week ahead of Friday’s big employment release. However, key earnings numbers were mixed today, and failed to generate enough of a positive story to counter the bank failure news. It should be noted that volume in most financial instruments — stocks, bonds and currencies combined — was light, which suggests some uneven positioning as investors either wait for some of this week’s heavy economic calendar to play out, or as they hold out for more convincing signs of a turn in the earnings news.

Looking ahead to Tuesday’s session, the market gets the first taste of economic data this week, first with the Case Shiller Home Price Index at 9:00 a.m. ET, then from Consumer Confidence data at 10:00. The Case Shiller data is somewhat dated, but the confidence report is for the July time frame.

Crude oil prices were modestly higher throughout the session, which also played into investor concerns about the growth and inflation outlook heading toward all these key economic reports this week. Crude oil futures gained about $1.50 dollars a barrel today, or about 1.2%, pushing close to $125 by the end of the U.S. trading session. Attacks by Nigerian rebels on pipelines lifted energy prices, but concern . . .

[ More » ]
Will Atkinson

Bancorp Bank, Consolidated Graphics and Gramercy Capital among 52-week lows

Bancorp Bank (Nasdaq:TBBK), Consolidated Graphics Inc (Nasdaq:CGX) and Gramercy Capital Corp (Nasdaq:GKK) are among the new 52-week lows in Monday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Frequency Electronics Inc (Nasdaq:FEIM), Home Inns & Hotels Management Inc (Nasdaq:HMIN), Severn Bancorp Inc (Nasdaq:SVBI), Sciele Pharma Inc (Nasdaq:SCRX), Ryland Group Inc (Nasdaq:RYL) and Provident Financial Holdings Inc (Nasdaq:PROV).

Here are the new 52-week lows among small caps:
[ More » ]
Dianna Heitz

Sciele Pharma drops 15% after Mylan wins generic Sular approval

Sciele Pharma Inc. (Nasdaq:SCRX) is off 15% today after competitor Mylan Inc. (NYSE:MYL) announced it had gained approval for the generic form of one of Sciele's medications. Sciele’s patent for Sular, a blood-pressure drug, expired on June 8. Pharmaceutical giant Mylan said shipments of the Sular generic would begin immediately.

In today’s trading, shares of Sciele are at $17.46 at 2:58 p.m. ET, down $3.14 from Friday’s close. Trading volume has soared to nearly 4 million shares, well above the average of 700,000. Earlier in the trading day, shares fell to a 52-week low of $17.39.
[ More » ]
Will Atkinson

American Axle & Manufacturing Holdings, Independent Bank and Bancorp Bank lead small-cap percentage losers

American Axle & Manufacturing Holdings Inc (Nasdaq:AXL), Independent Bank Corp (Michigan) (Nasdaq:IBCP) and Bancorp Bank (Nasdaq:TBBK) are among the biggest percentage losers in Monday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Sciele Pharma Inc (Nasdaq:SCRX), Advanta Corp(Nasdaq:ADVNB), SI Financial Group Inc (Nasdaq:SIFI), Consolidated Graphics Inc (Nasdaq:CGX), Chimera Investment Corp (Nasdaq:CIM) and Global Traffic Network Inc (Nasdaq:GNET).

Here are the biggest percentage losers among small caps:
[ More » ]
Jennifer Allen

Sciele Pharma: A Sular eclipse

Whether calming allergies, lowering cholesterol or treating diabetes, Sciele Pharma Inc. (Nasdaq: SCRX) is going to be very busy this year. Next year may be just as lively, as the company continues to expand into pediatrics and women’s health while maintaining its strength in the cardiovascular and diabetes arena.

Sciele (rhymes with dial) has seven products to launch in 2008, starting in January with Prandin for type-2 diabetes. In March, Sciele will launch its new Sular formulation for hypertension; other introductions  include an allergy drug via an agreement with Sanofi Aventis, a cholesterol reducer, a prenatal vitamin, a head lice asphyxiator (just in time for the back-to-school season) and another diabetes offering. Next year’s slate includes a hypertension drug and remedies for pediatric chronic excessive drooling and other maladies.

There will be more if Sciele gets its way. The Atlanta, Ga.-based company’s key is to grow through licensing and by acquiring products in late stage review. It also purchases commercialized drugs for sale in the United States — usually from large pharmaceutical companies. Its licenses and products come from AstraZeneca, Bayer AG, Warner-Lambert, Sanofi-Aventis, Wyeth, Elan and Novo Nordisk, among others. It depends on third-party manufacturers and its own sales force.

Sciele’s active pipeline is why focusing on the company’s switch to Sular from its old formula is investing through a rear view mirror. Sales of Sular fell in the fourth quarter ended Dec. 31 as Sciele geared up for the March launch of new Sular sales. Lower sales are expected again in the first quarter of this year, but then they should begin to build as the transition is completed. There aren’t high growth hopes for Sular, anyway: generics are likely to come onto the market by summer, and Sular is an out-of-favor calcium channel blocker drug for hypertension.   

Costs of the switch, while aggravating to investors, have virtually been absorbed and the groundwork is set for the upcoming launches. Given that, Sciele reiterated guidance for diluted earnings per share in 2008 at $1.97 to $2.07, with 40% of that expected in the first half of the year and 60% in the second half. That’s up from $1.56 per share — excluding non-operating costs — in 2007. Revenues are expected to grow 15% to 19% to $440 million to $455 million.

[ More » ]
Alex Alexandrov

Russell 2000 futures higher

The Russell 2000 (NYSE: IWM) futures are rising and the small-cap index will probably open in the green following news of employment data.

Private sector employment in the United States increased by 40,000 in the month of December, according to a report by Automatic Data Processing, Inc. (NYSE: ADP). Employment in the service-providing sector of the economy grew 71,000, while employment in the goods-producing sector declined 31,000, the Roseland, N.J.-based provider of business outsourcing solutions said.

However, December’s increase of 40,000 shows a slowing of nonfarm private employment growth that averaged 118,000 during the three-month period from September through November.

That’s consistent with a slowing economy.

Separately, the U.S. Labor Department reported that jobless claims for the week ended Dec. 29 fell 21,000 to 336,000 from the previous week’s upwardly revised figure of 357,000.

Investors will also be waiting to see data on factory orders for November, set to be released by the U.S. Census Bureau at 10 a.m. ET. Statistics released on Wednesday showed a surprise decline in U.S. manufacturing in December, the news of which sent stocks tumbling.

Here are the biggest percentage gainers and losers in pre-market trading among companies with a market cap between $100 million and $750 million:

Biggest percentage gainers:

KongZhong Corp. (KONG), up 13% on news it has signed a strategic alliance agreement with China Sports Industry Group Co.
Sciele Pharma Inc. (SCRX), up 10% on news it has received approval to sell a new version of its high blood pressure drug.
NightHawk Radiology Holdings, Inc. (NHWK), up 9%.

[ More » ]
Jennifer Schonberger

Sciele Pharma receives FDA approval for Sular formulation

Shares of Sciele Pharma, Inc. (Nasdaq: SCRX) are advancing this morning after the pharmaceutical company reported late Wednesday evening that the U.S. Food & Drug Administration has approved four dosage strengths of Sular formulation, a high blood pressure treatment.

The new Sular formulation, which uses SkyePharma's (LSE: SKP) patented GEOMATRIX technology, provides a lower dose of Sular for each of its current doses.

The company said it expects to launch the new Sular formulation during the first quarter of 2008.

Shares of Sciele Pharma (SCRX) jumped 18.45%, or $3.66, to $23.50 in pre-market. Shares of Sciele Pharma have been trading in the range of $19.70 to $28.83 for the past 52 weeks.

[ More » ]